CAMP4 Therapeutics

Contributing Author

Recent Articles by CAMP4 Therapeutics

Aug-14	CAMP4 Reports Second Quarter 2025 Financial Results and Corporate Highlights CAMP GlobeNewswire
May-16	CAMP4 Presents Translational Data from SYNGAP1-Related Disorders Program Showcasing Increased Protein in Non-Human Primates and Reviews Preclinical and Detailed Single Ascending Dose Safety Data from Urea Cycle Disorders Program at the 28th American Society of Gene and Cell Therapy Annual Meeting CAMP GlobeNewswire
May-13	CAMP4 Reports First Quarter 2025 Financial Results and Corporate Highlights CAMP GlobeNewswire